220 related articles for article (PubMed ID: 28039458)
1. Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors.
Cirello V; Vaira V; Grassi ES; Vezzoli V; Ricca D; Colombo C; Bosari S; Vicentini L; Persani L; Ferrero S; Fugazzola L
Oncotarget; 2017 Feb; 8(6):9752-9766. PubMed ID: 28039458
[TBL] [Abstract][Full Text] [Related]
2. SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways.
Grassi ES; Vezzoli V; Negri I; Lábadi Á; Fugazzola L; Vitale G; Persani L
Oncotarget; 2015 Nov; 6(34):36383-99. PubMed ID: 26415230
[TBL] [Abstract][Full Text] [Related]
3. Tumor and normal thyroid spheroids: from tissues to zebrafish.
Cirello V; Gaudenzi G; Grassi ES; Colombo C; Vicentini L; Ferrero S; Persani L; Vitale G; Fugazzola L
Minerva Endocrinol; 2018 Mar; 43(1):1-10. PubMed ID: 28146140
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration.
Parascandolo A; Rappa F; Cappello F; Kim J; Cantu DA; Chen H; Mazzoccoli G; Hematti P; Castellone MD; Salvatore M; Laukkanen MO
Sci Rep; 2017 Feb; 7():41416. PubMed ID: 28216675
[TBL] [Abstract][Full Text] [Related]
5. Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.
Dawson SJ; Conus NM; Toner GC; Raleigh JM; Hicks RJ; McArthur G; Rischin D
Anticancer Drugs; 2008 Jun; 19(5):547-52. PubMed ID: 18418222
[TBL] [Abstract][Full Text] [Related]
6. NITRIC OXIDE SYNTHASE ACTIVITY AND ITS CONCENTRATION IN THE TISSUES OF HUMAN THYROID CARCINOMAS.
Kalinichenko OV; Myshunina TM; Tron’ko MD
Fiziol Zh (1994); 2016; 62(3):9-19. PubMed ID: 29569867
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenic and metastatic activity of human thyroid cancer stem cells.
Todaro M; Iovino F; Eterno V; Cammareri P; Gambara G; Espina V; Gulotta G; Dieli F; Giordano S; De Maria R; Stassi G
Cancer Res; 2010 Nov; 70(21):8874-85. PubMed ID: 20959469
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
9. Multikinase inhibitors in thyroid cancer.
Licitra L; Locati LD
Ann Oncol; 2012 Sep; 23 Suppl 10():x328-33. PubMed ID: 22987985
[No Abstract] [Full Text] [Related]
10. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
Lin SF; Lin JD; Hsueh C; Chou TC; Wong RJ
PLoS One; 2017; 12(2):e0172315. PubMed ID: 28207834
[TBL] [Abstract][Full Text] [Related]
11. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
12. High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
Toteda G; Lupinacci S; Vizza D; Bonofiglio R; Perri E; Bonofiglio M; Lofaro D; La Russa A; Leone F; Gigliotti P; Cifarelli RA; Perri A
J Endocrinol Invest; 2017 Feb; 40(2):153-162. PubMed ID: 27592355
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
14. Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer.
Borson-Chazot F; Dantony E; Illouz F; Lopez J; Niccoli P; Wassermann J; Do Cao C; Leboulleux S; Klein M; Tabarin A; Eberle MC; Benisvy D; de la Fouchardière C; Bournaud C; Lasolle H; Delahaye A; Rabilloud M; Lapras V; Decaussin-Petrucci M; Schlumberger M
Thyroid; 2018 Sep; 28(9):1174-1179. PubMed ID: 30105951
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V
Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
17. Human follicular and papillary thyroid carcinoma cells interact differently with human venous endothelial cells.
Grimm D; Bauer J; Kromer E; Steinbach P; Riegger G; Hofstädter F
Thyroid; 1995 Jun; 5(3):155-64. PubMed ID: 7580262
[TBL] [Abstract][Full Text] [Related]
18. Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
Masaki C; Sugino K; Saito N; Saito Y; Tanaka T; Ogimi Y; Maeda T; Osaku T; Akaishi J; Hames KY; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
Endocr J; 2017 Aug; 64(8):819-826. PubMed ID: 28659544
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Akt activity in human thyroid tumors.
Guda BB; Pushkarev VV; Zhuravel OV; Kovalenko AY; Pushkarev VM; Taraschenko YM; Tronko MD
Ukr Biochem J; 2016; 88(5):90-5. PubMed ID: 29235817
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.
Owens LV; Xu L; Dent GA; Yang X; Sturge GC; Craven RJ; Cance WG
Ann Surg Oncol; 1996 Jan; 3(1):100-5. PubMed ID: 8770310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
